Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for VERO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2025 61.62M
June 30, 2025 63.08M
March 31, 2025 63.46M
December 31, 2024 68.18M
September 30, 2024 72.28M
June 30, 2024 79.75M
March 31, 2024 85.08M
December 31, 2023 93.65M
September 30, 2023 98.92M
June 30, 2023 106.16M
March 31, 2023 112.81M
December 31, 2022 125.38M
September 30, 2022 120.63M
June 30, 2022 132.75M
March 31, 2022 144.42M
December 31, 2021 157.37M
September 30, 2021 138.15M
June 30, 2021 147.27M
Date Value
March 31, 2021 148.76M
December 31, 2020 160.52M
September 30, 2020 147.02M
June 30, 2020 150.92M
March 31, 2020 155.26M
December 31, 2019 191.13M
September 30, 2019 20.75M
June 30, 2019 23.18M
March 31, 2019 29.82M
December 31, 2018 125.13M
September 30, 2018 37.74M
June 30, 2018 29.04M
March 31, 2018 25.88M
December 31, 2017 32.97M
September 30, 2017 16.04M
June 30, 2017 18.15M
March 31, 2017 13.48M
December 31, 2016 19.50M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Hypertension Diagnostics, Inc. --
Avitar, Inc. --
Abbott Laboratories 109.22B
AngioDynamics, Inc. 267.16M
Alphatec Holdings, Inc. 791.03M

Total Assets (Quarterly) Related Metrics